Table 2.
LncRNA | Expression | Target genes | Related genes | Model | Region | Functions | Reference |
---|---|---|---|---|---|---|---|
XIST | Up | miR-150 | ZEB1 | CCI rat model | Spinal cord, microglial | Neuroinflammation | [102] |
miR-137 | TNFAIP1 | CCI rat model | Spinal cord, microglial | Neuroinflammation | [103] | ||
miR-154-5p | TLR5 | CCI rat model | Spinal cord, microglial | Neuroinflammation | [104] | ||
miR-494 | STAT3 | SCI rat model | Spinal cord | Apoptosis | [105] | ||
miR-544 | STAT3 | CCI rat model | Spinal cord, microglial | Neuroinflammation | [18] | ||
miR-146a | Nav1.7 | CFA rat model | DRG | Neuroinflammation | [106] | ||
MALAT1 | Up | miR-154-5p | AQP9 | CCI rat model | Spinal cord, microglia | Neuroinflammation | [107] |
miR-129-5p | BDNF | PNI mice model | Schwann cell | Proliferation and migration | [108] | ||
miR-129-5p | HMGB1 | CCI rat model | Spinal cord, microglia | Neuroinflammation | [109] | ||
miR-206 | ZEB2 | CCI rat model | Spinal cord, microglial | Neuroinflammation | [110] | ||
uc.48+ | Up | P2X7 receptor | p-ERK1/2 | TN rat model | Trigeminal ganglia | Phosphorylation | [111] |
– | Diabetic rat model | DRG | Neuroinflammation | [112] | |||
p-ERK1/2 | Diabetic rat model | Superior cervical ganglia | Autonomic neuropathy | [113] | |||
BC168687 | Up | P2X7 receptor | – | Diabetic rat model | DRG | Neuroinflammation | [114] |
TRPV1 | TNF-α, IL-1β, ERK, MAPK | Diabetic rat model | DRG | Neuroinflammation | [115] | ||
P2X7, TRPV1 receptor | – | Diabetic rat model | DRG | Neuronal excitability | [116] | ||
NONRATT021972 | Up | P2X3 receptor | ERK1/2, p-ERK | Diabetic rat model | DRG | Neuroinflammation | [117] |
P2X7 receptor | – | Diabetic rat model | Superior cervical ganglion, PC12 cell | Neuroinflammation | [118] | ||
P2X7 receptor | – | Diabetic rat model | DRG | Neuroinflammation | [119] | ||
BC088259 | Up | Vimentin | – | SNI rat model | Schwann cell | Migration | [120] |
Linc00657 | Up | miR-136 | ZEB1 | CCI rat model | Spinal cord, microglial | Neuroinflammation | [121] |
CRNDE | Up | miR-136 | IL6R | CCI rat model | Spinal cord, microglial | Neuroinflammation | [122] |
NEAT1 | Up | miR-381 | HMGB1 | CCI rat model | Spinal cord, microglial | Neuroinflammation | [19] |
uc.153 | Up | miR-182-5p | EphB1-NMDA receptors | CCI mice model | Spinal cord | Neuronal excitability | [123] |
Linc00052 | Up | miR-448 | JAK1 | SNL rat model | Spinal cord, PC12 cell | Neuroinflammation | [124] |
Linc00311, AK141205 | Up | STAT3 | CCL-2, COX-2, IL-1β, IL-6, and TNF-α | CCI rat model | Microglia | Neuroinflammation | [125] |
SNHG5 | Up | miR-154-5p | CXCL13 | CCI rat model | DRG, microglia | Astrocyte inhibition, microglia activation | [126] |
H19 | Up | – | – | SNL rat model | DRG | Neuroinflammation | [127] |
H19 | Up | – | – | SNL mice model | DRG, DRG cell | Neuronal excitability | [128] |
PKIA-AS1 | Up | – | CDK6 | SNL rat model | Spinal cord | Neuroinflammation | [129] |
BC088327 | Up | – | Heregulin-1β | PNI rat model | Sciatic nerve | Proliferation | [130] |
MRAK009713 | Up | P2X3 receptor | – | CCI rat model | DRG | Neuronal excitability | [131] |
Kcna2 AS RNA | Up | Kcna2 mRNA | G9a | CCI/SNL mice model | DRG | Neuronal excitability | [132] |
Kcna2 mRNA | – | CCI/SNL rat model | DRG | Neuronal excitability | [133] | ||
DGCR5 | Down | miR-330-3p | PDCD4 | CCI rat model | Spinal cord, microglial | Neuroinflammation | [134] |
TNXA-PS1 | Down | miR-24-3p/miR-152-3p | Dusp1 | SNI rat model | DRG | Migration | [135] |
CCAT1 | Down | miR-155 | SGK3 | CCI rat model | DRG, spinal cord, hippocampus, anterior cingulate cortex, PC12 cell | Neuronal excitability | [136] |
uc.217 | Down | – | – | SNI rat model | DRG | Neurite outgrowth | [137] |
BC089918 | Down | – | – | SNI rat model | DRG | Nerve regeneration | [138] |
CCI = sciatic nerve chronic constriction injury; SCI = spinal cord injury; CFA = complete Freund’s adjuvant; PNI = peripheral nerve injury; TN = trigeminal neuralgia; DRG = dorsal root ganglia; XIST = X-inactive specific transcript; ZEB1 = zinc finger E-box-binding homeobox 1; TNFAIP1 = tumor necrosis factor alpha-induced protein 1; TLR5 = toll-like receptor 5; STAT3 = signal transducer and activator of transcription 3; MALAT1 = metastasis-associated lung adenocarcinoma transcript 1; AQP9 = aquaporin 9; BDNF = brain-derived neurotrophic factor; HMGB1 = high mobility group protein B1; TRPV1 = transient receptor potential vanilloid type 1; IL = interleukin; TNF-α = tumor necrosis factor-α; ERK = extracellular regulated protein kinases; MAPK = mitogen-activated protein kinases; CRNDE = Colorectal Neoplasia Differentially Expressed; JAK1 = Janus kinase 1; CCL-2 = chemokine CC motif ligand 2; COX-2 = cyclooxygenase 2; SNHG5 = small nucleolar RNA host gene 5; CXCL13 = C-X-C motif chemokine 13; CDK6 = cyclin-dependent kinases 6; NF-κВ = nuclear factor-κВ; Dusp 1 = Dual-specificity phosphatase 1; CCAT1 = colon cancer–associated transcript-1; SGK3 = Serum and glucocorticoid–regulated protein kinase 3